IP Verse

Symbiosis competitive analysis

Loading summary...

Explore patent oppositions filed by Symbiosis against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3498734	Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer	MERCK SHARP & DOHME	May 26, 2022
EP3283882	Blood-Based Biomarkers Of Tumor Sensitivity To Pd-1 Antagonists	MERCK SHARP & DOHME	Sep 15, 2021

Explore the latest publications and patents granted to Symbiosis, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Symbiosis, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Symbiosis with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
SYMBIOSIS	2	-	-	-
MERCK SHARP & DOHME	20	42	54	5
PFIZER	51	87	43	12